Utilities Registry

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 11 - 20 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of COVID-19 health state utilities (Granholm A et al. Acta Anaesthesiol Scand 2023. doi:10.1111/aas.14231)	2020 - 2021	EQ-5D-5L	Denmark, India, Sweden, Switzerland	COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 982 patients in COVID STEROID 2 trial
Title Selection of neurological disease health state utilities (Janssen N et al., J Alzheimers Dis. 2022. doi:10.3233/JAD-215304)	Year(s) of data collection 2009 - 2011	Valuation Method SF-6D	Country Finland	Condition Cognitive decline
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 1120 participants with longitudinal 2-year data from the FINGER study to investigate the association between cognition, health related quality of life, and costs in a population at risk for cognitive decline
Title Selection of autoimmune disease health state utilities (Armuzzi A et al., BMC Gastroenterol. 2023. doi:10.1186/s12876-023-02640-7)	Year(s) of data collection 2020 - 2021	Valuation Method EQ-5D-5L	Country France, Germany, Italy, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Ulcerative colitis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics a point-in-time survey of 164 matched patients treated with tofacitinib
Title Selection of mental health health state utilities (Stolz M et al., Eur J Health Econ. 2022. doi:10.1007/s10198-022-01543-w)	Year(s) of data collection 2008 - 2013	Valuation Method EQ-5D-3L, SF-6D	Country Germany	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 566 cardiac patients with depressive symptoms as part of the SPIRRCAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial
Title Selection of orthopedic and musculoskeletal health state utilities (Panzram B et al., J Clin Med. 2023. doi:10.3390/jcm12041694)	Year(s) of data collection 2012 - 2016	Valuation Method EQ-5D-3L	Country Germany	Condition Knee replacement
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics 201 participants in a retrospective single-center cohort study of patients who underwent cementless OUKR to investigate the clinical and functional results of cementless unicompartmental knee arthroplasty with a minimum follow up of 5 years
Title Selection of autoimmune disease health state utilities (Mitsikostas DD et al., Adv Ther. 2023. doi:10.1007/s12325-022-02388-8)	Year(s) of data collection 2012 - 2016	Valuation Method EQ-5D-3L	Country Greece	Condition Multiple sclerosis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics A prospective observational study of 458 participants under treatment with fingolimod conducted by hospital-based and private practice neurologists
Title Selection of orthopedic and musculoskeletal health state utilities (Kontodimopoulos N et al., J Clin Med. 2022. doi:10.3390/jcm11144097)	Year(s) of data collection 2020	Valuation Method EQ-5D-3L, EQ-5D-5L, SF-6D	Country Greece	Condition Ankylosing spondylities, Musculoskeletal disorders, Osteopenia/Osteporosis, Psoriaticc arthritis, Rheumatiod arthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A cross-sectional sample of 315 (total) consecutive patients clinically diagnosed with RA, PsA, AS, or OsP/OP
Title Selection of general population health health state utilities (Nikl A et al., Health Qual Life Outcomes. 2023. doi:10.1186/s12955-023-02096-z)	Year(s) of data collection 2021	Valuation Method 15D, EQ-5D-5L	Country Hungary	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 1887 participants in the online cross-sectional survey
Title Selection of COVID-19 health state utilities (Chakravarty R et al., Indian J Psychol Med. 2023. doi:10.1177/02537176221140557)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 80 COVID-19 patients treated with single infusion tocilizumab or no treatment
Title Selection of COVID-19 health state utilities (Shah C et al., Lung India. 2023. doi:10.4103/lungindia.lungindia_126_22)	Year(s) of data collection 2021	Valuation Method EQ-5D-3L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 388 patients with confirmed COVID-19 who had been treated and discharged after hospitalization

← Previous results Next results →